Antihypertensive drug use in resistant and nonresistant hypertension and in controlled and uncontrolled resistant hypertension. Issue 7 (July 2018)

• Record Type: Journal Article
• Authors: de la Sierra, Alejandro; Armario, Pedro; Oliveras, Anna; Banegas, José R.; Gorostidi, Manuel; Vinyoles, Ernest; de la Cruz, Juan J.; Segura, Julián; Ruilope, Luis M.
• Is Part Of: Journal of hypertension. Volume 36:Issue 7(2018:Jul.)
• Publication Date: 2018-07
• Subjects: ambulatory blood pressure monitoring -- antihypertensive drugs -- blood pressure control -- combination therapy -- resistant hypertension; Hypertension -- Periodicals; Hypertension -- Periodicals; 616.132005
• DOI: 10.1097/HJH.0000000000001729
• Languages: English
• ISSNs: 1473-5598

Abstract

Abstract : Background and aim: Treatment-resistant hypertension (TRH) is associated with particular clinical features, nonadherence, and suboptimal treatment. We assessed possible associations of antihypertensive drug classes, specific agents inside each class, and types of combinations, with the presence of non-TRH vs. TRH, and with controlled vs. uncontrolled TRH. Methods: Comparisons were done in 14 264 patients treated with three drugs (non-TRH: 2988; TRH: 11 276) and in 6974 treated with at least four drugs (controlled TRH: 1383; uncontrolled TRH: 5591). Associations were adjusted for age, sex, and previous cardiovascular event. Results: In both groups of patients treated with three or with at least four drugs, aldosterone antagonists among drug classes [adjusted odds ratio (OR): 1.82 and 1.41, respectively], and ramipril (OR: 1.28 and 1.30), olmesartan (OR: 1.31 and 1.37), and amlodipine (OR: 1.11 and 1.41) inside each class were significantly associated with blood pressure control (non-TRH or controlled TRH). In patients treated with three drugs, non-TRH was also associated with the use of chlorthalidone (OR: 1.50) and bisoprolol (OR: 1.19), whereas in patients treated with at least four drugs, controlled TRH was significantly associated with the triple combination of a renin–angiotensin system blocker, a calcium channel blocker, and a diuretic (OR: 1.17). Conclusion: The use of aldosterone antagonists is associated with blood pressure control in patients treated with three or more drugs. Similar results are observed with specific agents inside each class, being ramipril, olmesartan, chlorthalidone, amlodipine, and bisoprolol those exhibiting significant results. An increased use of these drugs might probably reduce the burden of TRH. Abstract : Supplemental Digital Content is available in the text